- Home
- GNFT vs EDD Comparison
GNFT vs EDD Comparison
Compare GNFT & EDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- EDD
- Stock Information
- Founded
- GNFT 1999
- EDD 2007
- Country
- GNFT France
- EDD United States
- Employees
- GNFT N/A
- EDD N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- EDD Finance Companies
- Sector
- GNFT Health Care
- EDD Finance
- Exchange
- GNFT Nasdaq
- EDD Nasdaq
- Market Cap
- GNFT 190.6M
- EDD 304.3M
- IPO Year
- GNFT 2019
- EDD N/A
- Fundamental
- Price
- GNFT $3.71
- EDD $4.44
- Analyst Decision
- GNFT Strong Buy
- EDD
- Analyst Count
- GNFT 1
- EDD 0
- Target Price
- GNFT $13.00
- EDD N/A
- AVG Volume (30 Days)
- GNFT 7.9K
- EDD 254.3K
- Earning Date
- GNFT 09-19-2024
- EDD 01-01-0001
- Dividend Yield
- GNFT N/A
- EDD 7.52%
- EPS Growth
- GNFT N/A
- EDD N/A
- EPS
- GNFT 0.47
- EDD N/A
- Revenue
- GNFT $86,225,222.00
- EDD N/A
- Revenue This Year
- GNFT $155.44
- EDD N/A
- Revenue Next Year
- GNFT N/A
- EDD N/A
- P/E Ratio
- GNFT $7.55
- EDD N/A
- Revenue Growth
- GNFT 175.45
- EDD N/A
- 52 Week Low
- GNFT $3.31
- EDD $4.22
- 52 Week High
- GNFT $6.42
- EDD $4.95
- Technical
- Relative Strength Index (RSI)
- GNFT 33.06
- EDD 35.76
- Support Level
- GNFT $3.63
- EDD $4.34
- Resistance Level
- GNFT $3.94
- EDD $4.43
- Average True Range (ATR)
- GNFT 0.13
- EDD 0.06
- MACD
- GNFT 0.03
- EDD -0.02
- Stochastic Oscillator
- GNFT 19.17
- EDD 22.62
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.